Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation

Bone Marrow Transplantation

Volumn 31, Issue 9, 2003, Pages 795-801

  Dettenkofer, M ^a   Ebner, W ^a   Bertz, H ^a   Babikir, R ^a   Finke, J ^a   Frank, U ^a   Ruden H ^b   Daschner, F D ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

BMT; HSCT; Neutropenia; Nosocomial infection; PBSCT; Surveillance

Indexed keywords

AMPHOTERICIN; CIPROFLOXACIN; COTRIMOXAZOLE; FLUCONAZOLE; METRONIDAZOLE;

ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BACTEREMIA; CLOSTRIDIUM DIFFICILE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE DURATION; ENTEROCOCCUS; FEMALE; GASTROENTERITIS; GERMANY; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL INFECTION; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PNEUMONIA; PRIORITY JOURNAL; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; BONE MARROW TRANSPLANTATION; CROSS INFECTION; GERMANY; HUMANS; INCIDENCE; MIDDLE AGED; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0038075105     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703920     Document Type: Article

References (41)

1. Perl TM, Chotani R, Agawala R. Infection control and prevention in bone marrow transplant patients. In: Mayhall CG (ed.). Hospital Epidemiology and Infection Control, 2nd edn. Lippincott Williams & Willkins: Philadelphia, 1999, pp 803-844.
2. Carlisle PS, Gucalp R, Wiernik PH. Nosocomial infections in neutropenic cancer patients. Infect Control Hosp Epidemiol 1993; 14: 320-324.
3. Emmerson AM. The impact of surveys on hospital infection. J Hosp Infect 1995; 30 (Suppl.): 421-440.
4. Dettenkofer M, Daschner F. Cost-effectiveness of surveillance methods. In: Emmerson AM, Ayliffe GAJ (eds). Surveillance of Nosocomial Infections. Ballière Tindall: London. Bailliere's Clin Infect Dis 1996; 3: 289-301.
5. Gastmeier P, Sohr D, Just HM et al. How to survey nosocomial infections. Infect Control Hosp Epidemiol 2000; 21: 366-370.
6. Gaynes RP, Horan TC. Surveillance of nosocomial infections. In: Mayhall CG (ed.). Hospital Epidemiology and Infection Control, 2nd edn. Lippincott Williams & Willkins: Philadelphia, 1999, pp 1285-1317.
7. NNIS. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992-April 2000, issued June 2000. Am J Infect Control 2000; 28: 429-448.
8. Howell PB, Walters PE, Donowitz GR et al. Risk factors for infection of adult patients with cancer who have tunnelled central venous catheters. Cancer 1995; 75: 1367-1375.
9. Hunter AE, Haynes AP, Russell NH. Bone marrow transplantation: current situation, complications and prevention. J Antimicrob Chemother 1995; 36 (Suppl. 13): 119-133.
10. Kruger W, Russmann B, Kroger N et al. Early infections in patients undergoing bone marrow or blood stem cell transplantation - a 7 year single centre investigation of 409 cases. Bone Marrow Transplant 1999; 23: 589-597.
11. Ninin E, Milpied N, Moreau P. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis 2001; 33: 41-47.
12. Sparrelid E, Hägglund H, Remberger M et al. Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection. Bone Marrow Transplant 1998; 22: 795-800.
13. Williamson ECM, Millar MR, Steward CG et al. Infections in adults undergoing unrelated donor bone marrow transplantation. Br J Haematol 1999; 104: 560-568.
14. Marena C, Zecca M, Careinini ML et al. Incidence of, and risk factors for, nosocomial infections among hematopoietic stem cell transplantation recipients, with impact on procedure-related mortality. Infect Control Hosp Evidemiol 2001; 22: 510-517.
15. Gratwohl A, Passweg J, Baldomero H, Urbano-Ispizua A; European Group for Blood and Marrow Transplantation (EBMT), Hemato stem cell transplantation activity in Europe 1999: Bone marrow Transplant 2001; 27:899-916.
16. Perl TM. Surveillance, reporting, and the use of computers. In: Wenzel R (ed.). Prevention and Control of Nosocomial Infections. 3rd edn. Williams & Willkins: Baltimore, 1997, pp 127-161.
17. Garner JS, Jarvis WR, Emori GT et al. CDC definition for nosocomial infections. Am J Infect Control 1988; 16: 128-140.
18. Rosner B. Fundamentals of Biostatistics, 3rd edn. Duxburg Press: Boston, 1990, p 88ff.
19. Johnson PW, Simnett SJ, Sweetenham JW et al. Bone marrow and peripheral blood stem cell transplantation for malignancy. Health Technol Assess 1988; 2: 1-187.
20. Margolis J, Borrello I, Flinn IW. New approaches to treating malignancies with stem cell transplantation. Semin Oncol 2000; 27: 524-530.
21. Jacobs P, Hailey D, Turner R et al. Allogeneic stem cell transplantation. An economic comparison of bone marrow, peripheral blood, and cord blood technologies. Int J Technol Assess Health Care 2000; 16: 874-884.
22. Hui CH, To LB. Peripheral stem cells in bone marrow transplantation Future prospects. Baillieres Best Pract Res Clin Haematol 1999; 12: 307-318.
23. Saba N, Abraham R, Keating A. Overview of autologous stem cell transplantation. Crit Rev Oncol Hematol 2000; 36: 27-48.
24. DiPersio JF, Khoury H, Haug et al. Innovations in allogeneic stem-cell transplantation. Semin Hematol 2000; 37 (Suppl. 2): 33-41.
25. Hanna H, Raad I, Gonzalez V et al. Control of nosocomial Clostridium difficile transmission in bone marrow transplant patients. Infect Control Hosp Epidemiol 2000; 21: 226-228.
26. Klausner JD, Zukerman C, Limaye AP et al. Outbreak of Stenotrophomonas maltophilia bacteremia among patients undergoing bone marrow transplantation: association with faulty replacement of handwashing soap. Infect Control Hosp Epidemiol 1999; 20: 756-758.
27. Kirkpatrick BD, Harrington SM, Smith D et al. An outbreak of vancomycin-dependent Enterococcus faecium, in a bone marrow transplant unit. Clin Infect Dis 1999; 29: 1268-1273.
28. Chadwick PR, Oppenheim BA, Fox A et al. Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit. J Hosp Infect 1996; 34: 171-182.
29. Kolbe K, Domkin D, Derigs HG et al. Infections complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Transplant 1997; 19: 143-147.
30. Hughes WT, Flynn PM, Williams BG. Nosocomial infection in patients with neoplastic disease. In: Mayhall CG (ed.). Hospital Epidemiology and Infection Control. Williams & Wilkins: Baltimore, 1996, pp 618-631.
31. Yuen KY, Woo PC, Hui CH et al. Unique risk factors for bacteraemia in allogeneic bone marrow transplant recipients before and after engraftment. Bone Marrow Transplant 1998; 21: 1137-1143.
32. Elishoov H, Or R, Strauss N, Engelhard D. Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplant recipients. A 5-year prospective study. Medicine (Baltimore) 1998; 77: 83-101.
33. Kumagai T, Sakamaki H, Tanikawa S et al. Utility and safety of Hickman catheters for venous access after bone marrow transplantation. Intern Med 1998; 37: 286-291.
34. Lossos IS, Breuer R, Or R et al. Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. Transplantation 1995; 60: 672-678.
35. Chakrabarti S, Lees A, Jones SG et al. Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality. Bone Marrow Transplant 2000; 26: 871-876.
36. Collin BA, Leather HL, Wingard JR et al. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 BMT patients. Clin Infect Dis 2001; 33: 947-953.
37. La Rosa AM, Champlin RE, Mirza N et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 2001; 32: 871-876.
38. Jantunen E, Ruutu P, Niskanen L, Volin L et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 1997; 19: 801-808.
39. Haley RW, Culver DH, White JW et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in U.S. hospitals. Am J Epidemiol 1985; 212: 182-205.
40. Dettenkofer M, Ebner W, Els T et al. Surveillance of nosocomial infections in a neurology intensive care unit. J Neurol 2001; 248: 959-964.
41. Dykewicz CA. Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin Infect Dis 2001; 33: 139-144.